News | July 29, 2011

Landmark Cancer Treatment Supported by NICE

July 29, 2011 – The National Institute for Health and Clinical Excellence (NICE) has announced that it has produced guidance to support the routine use of selective internal radiation therapy (SIRT) for the treatment of patients with liver tumors resulting from colorectal cancer. This welcome decision culminates an extensive dialogue between patients, patient groups, clinical experts and parliamentarians.

SIRT is used for the treatment of inoperable liver tumors and involves injecting millions of tiny radioactive microspheres into the liver via the hepatic artery. Each microsphere is coated with a radioactive isotope that emits beta radiation. The radiation delivers a localized treatment to tumor cells while conserving normal liver cells. SIR-Spheres microspheres, a form of SIRT, were approved in Europe in 2002 and at least 18,000 patients have been treated worldwide. Three hundred patients have received the treatment in Britain. The NICE guidance, released on July 27, 2011, found there is evidence that SIRT controls liver tumors from colorectal cancer, meaning that eligible National Health Service (NHS) patients are now likely to have improved access to this treatment.

Disproportionate access to SIRT has been of great concern to many cancer patients, as the treatment can potentially extend life by years. SIRT was originally assessed in 2004 and during the more recent reassessment there has been confusion among primary care trusts (PCTs) as to whether they should fund the treatment for eligible patients on the NHS. The reassessment of SIRT has taken NICE two years to complete.

In May 2010, the plight of Becky Smith, M.D., a 30-year-old NHS surgeon who was refused SIRT treatment by the Isle of Wight PCT because of funding issues, was highlighted by the national media. After receiving national support and offers of funding from individuals, Smith was told that the Isle of Wight PCT had made a dramatic U-turn and decided to fund her treatment. Smith has been campaigning for the government to change the system to make this life-saving treatment available to all who need it.

Smith said, "I have without doubt benefited from treatment with SIRT, which has given me precious time to live life to the full. It is great that NICE has supported the use of SIRT; however, this decision should have been made much sooner. I hope that this means all eligible patients will get the treatment that they deserve on the NHS."

Harpreet Wasan, M.D., consultant oncologist at Hammersmith Hospital, Imperial College, said, "SIRT is a pioneering treatment which provides an innovative therapy for patients with inoperable liver tumors that complements chemotherapy. It is excellent news that NICE has now clarified its guidance with the latest evidence and this should ensure appropriately eligible patients can access SIRT on the NHS. I hope that as a result, postcode prescribing and lengthy delays in approving eligible patients for the treatment will be eradicated."

For more information: www.guidance.nice.org.uk/ipg401

 

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init